Anzeige - Blood biomarkers in the NAKO Gesundheitsstudie (German National Cohort) at baseline: analysis and reliability of blood biomarkers from participants enrolled at the Berlin-North study center

Nutzungsanzeige

KeyNAKO-521

Project leadIlais Moreno Velásquez

Approval date22.12.2020

Published date22.12.2020

SummaryThe aim of this proposal is to characterize the completeness and plausibility of baseline biomarkers from NAKO participants enrolled at the Berlin-North study center (Max-Delbrück Center for Molecular Epidemiology, MDC). In addition, we aim to analyze the intra and inter-individual variability of biomarkers over one-year in a subset of study participants.

Keywords-

InstitutionsMax-Delbrück-Centrum für Molekulare Medizin, Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft (MDC), Max-Delbrück-Centrum für Molekulare Medizin (MDC)

Go back